Competitive Advantages and Performance of Stock Market: The Case of Egypt

Alber, Nader

doi:10.5539/ijef.v5n11p133

Cited by 7 publications

(3 citation statements)

References 48 publications

(36 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…• It is also clear that the causal trend between banking efficiency, banking competition and concentration may determine what the bank's policies and strategies should be directed in terms of enhancing the bank's efficiency and increasing its profits, by providing more innovation in products and enhancing the quality of banking products. Besides, performance may be affected by information security (Alber & Nabil, 2016) and by competitive advantages (Alber, 2013).…”

Section: Results Indicatementioning

confidence: 99%

Bank Efficiency, Competition and Concentration in MENA Region Countries: A Granger Causality Approach

Attia

Alber

2022

EJBMR

View full text Add to dashboard Cite

In this paper, we aim to explore the causal relationship among the bank efficiency, competition, and concentration in the banking systems of 15 countries in the MENA region (Jordan, UAE, Bahrain, Algeria, Saudi Arabia, Kuwait, Morocco, Turkey, Tunisia, Oman, Palestine, Qatar, Lebanon, Egypt, and Mauritania), by modeling econometric panel data over 2008–2018. Banking efficiency is measured by Data Envelopment Analysis (DEA), while the level of competition is measured by the Boone Indicator, and the level of concentration is measured by the HHI index. Granger causality is used to estimate the relationship among these variables. Results indicate the presence of a significant effect of banking efficiency on banking competition and banking concentration.

show abstract

Section: Results Indicatementioning

confidence: 99%

Bank Efficiency, Competition and Concentration in MENA Region Countries: A Granger Causality Approach

Attia

Alber

2022

EJBMR

View full text Add to dashboard Cite

show abstract

“…The third and fourth hypotheses were tested using the event study technique, through the following steps (Alber, 2013).…”

Section: Measuring Variablesmentioning

confidence: 99%

COVID-19 Vaccinations: Efficacy and Financial Benefits (The Case of the Pharmaceutical Companies)

Alber¹,

Abdelrhim²,

Farouh³

2023

IBR

View full text Add to dashboard Cite

This paper empirically investigates two sides of the COVID-19 vaccinations. The first part is a study of the vaccination efficacy and its impact on the number of new cases and new deaths, using the daily doses data of Eight different COVID-19 vaccination for a sample of 30 countries around the world. The second part is a study of the financial benefits for the same eight vaccines producers’ companies. The event study method is adopted in this research to explore the abnormal returns and its accumulations, the event date is January 30, 2020. The Vaccine’s efficacy results show that (Moderna, Oxford/Astrazeneca, and Novavax V) proved efficacy in reducing new cases and new deaths. Meanwhile, Cansino’s vaccine was effective in reducing the number of new cases only. On the other hand, vaccines like (Pfizer/ Biontech, Sinovac, Johnson & Johnson, and Sinopharm/ Beijing) didn’t prove efficacy in reducing the number of new cases and new deaths. The Financial benefits results show that the vaccine manufacturers who achieved the benefits of abnormal returns in the presence of vaccine efficacy are (Oxford/AstraZeneca and Novavax). While other manufacturers did not achieve the benefits of abnormal returns. The results also show that the pharmaceutical companies that achieved benefits on the cumulative abnormal returns in the presence of the vaccine efficacy are (Oxford/AstraZeneca, Novavax, Moderna, and CanSino). Meanwhile, the rest of manufacturers achieved cumulative abnormal returns but they are not effective in reducing the numbers of neither new cases nor new deaths.

show abstract

“…The first section deals with some recent literature on the economic and financial effects of COVID-19, while the second section deals with some literature related to the performance of financial markets, and finally the third section deals with literature related to the relationship between COVID-19 and financial markets. (Alber, 2013b) aims to analyze the effects of quality declaration on the performance of listed Egyptian companies. This was performed using a sample of 11 events, covering international and national quality certification declarations over the period from 2006 to 2012.…”

Section: Literature Reviewmentioning

confidence: 99%

The impact of the Coronavirus pandemic on the performance of the financial market: The case of the Sector indices in the Egyptian Stock Exchange

Khalil

2023

Alexandria Journal of Managerial Research and Information Syste

View full text Add to dashboard Cite

This paper aims to study the effect of coronavirus pandemic on the performance 0f the financial market in the Egyptian Stock Exchange, Coronavirus spread has been measured by "Total cases, daily cases, Total deaths and Daily deaths" on daily basis. The dependent variable reflects the response of the Egyptian sectorial indicators to the spread of the Coronavirus and is measured by the returns of the daily sectorial indicators for the Egyptian stock market; this has been applied on daily basis over the period from March 1, 2020 till October 31, 2021.Results indicate that the returns of the stock market sectors seems to be more sensitive to total indicators of mortality than daily deaths from coronavirus, and daily cases more than total cases of coronavirus. The coefficient of determination between the independent variables and the variable belonging to 4 sectors is (IT, Media & Communication Services 0.393, Industrial Goods, Services and Automobiles 0.470, Health Care & Pharmaceuticals 0.327, Basic Resources 0.266), While the correlation coefficient and the coefficient of determination between the independent variables and the dependent variable reached strong correlation ratios for 13 sectors of the stock exchange.

show abstract

Competitive Advantages and Performance of Stock Market: The Case of Egypt

Cited by 7 publications

References 48 publications

Bank Efficiency, Competition and Concentration in MENA Region Countries: A Granger Causality Approach

Bank Efficiency, Competition and Concentration in MENA Region Countries: A Granger Causality Approach

COVID-19 Vaccinations: Efficacy and Financial Benefits (The Case of the Pharmaceutical Companies)

The impact of the Coronavirus pandemic on the performance of the financial market: The case of the Sector indices in the Egyptian Stock Exchange

Contact Info

Product

Resources

About